The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
Open accessAbstract
AIM: The Framingham risk score (FRS) is one of the standard tools used to predict the incidence of coronary heart disease (CHD). No previous study has investigated its efficacy for a Japanese population cohort. The purpose of this study was to develop new coronary prediction algorithms for the Japanese population in the manner of the FRS, and to compare them with the original FRS. METHODS: Our coronary prediction algorithms for Japanese were based on a large population-based cohort study (Suita study). The study population comprised 5,521 healthy Japanese. They were followed-up for 11.8 years on average, and 213 cases of CHD were observed. Multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model. RESULTS: Our coronary prediction algorithms for Japanese patients were based on a large populationbased cohort study (the Suita study). A multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model. The C-statistics showed that the new model had better accuracy than the original and recalibrated Framingham scores. The net reclassification improvement (NRI) by the Suita score with the inclusion of CKD was 41.2% (P＜0.001) compared with the original FRS. The recalibration of the FRS slightly improved the efficiency of the prediction, but it was still worse than the Suita score with the CKD model. The calibration analysis suggested that the original FRS and the recalibrated FRS overestimated the risk of CHD in the Japanese population. The Suita score with CKD more accurately predicted the risk of CHD. CONCLUSION: The FRS and recalibrated FRS overestimated the 10-year risk of CHD for the Japanese population. A predictive score including CKD as a coronary risk factor for the Japanese population was more accurate for predicting CHD than the original Framingham risk scores in terms of the C-statics and NRI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There are several assessment tool that predict the absolute risk of ASCVD in the Japanese population.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [161]
In the citing paper
“In terms of absolute risk, aging enhances the risk for ASCVD and death from it much more than any other risk factors160–162).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,483
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
Cited by
Sorted by citations
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Self-citationOkamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Self-citationAn international multidisciplinary consensus statement on MAFLD and the risk of CVD
Zhou, X., Targher, G., Byrne, C. D., Somers, V. K., Kim, S. U., Chahal, C. A. A., Wong, V. W., Cai, J., Shapiro, M. D., Eslam, M., et al. (2023) · Hepatology International · doi:10.1007/s12072-023-10543-8 · Cited by 203
“Several studies from different countries showed that patients with MAFLD had a higher 10-year CVD risk (as estimated by the FRS or other CVD risk prediction tools) compared to those with NAFLD, thus confirming that MAFLD may identify a greater CVD risk burden [25, 27, 38, 39].”
BackgroundResultBiomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Sun, J. T., Axelsson, J., Machowska, A., Heimbürger, O., Barany, P. F., Lindholm, B., Lindström, K., Stenvinkel, P., & Qureshi, A. R. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10441015 · Cited by 183
“Over the last decade, multiple studies have attempted to identify better risk prediction tools specific to the CKD population (7,12,13).”
BackgroundTsutsumi, T., Eslam, M., Kawaguchi, T., Yamamura, S., Kawaguchi, A., Nakano, D., Koseki, M., Yoshinaga, S., Takahashi, H., Anzai, K., et al. (2021) · Hepatology Research · doi:10.1111/hepr.13685 · Cited by 170
“On the other hand, MAFLD was an independent factor for worsening of the Suita score that has been developed for Japanese patients.(8) Thus, MAFLD was an independent predictor only for worsening of Suita score, not for the Framingham risk score.”
BackgroundMethodInfluential
Metadata
- Authors
- Nishimura, K., Okamura, T., Watanabe, M., Nakai, M., Takegami, M., Higashiyama, A., Kokubo, Y., Okayama, A., & Miyamoto, Y.
- Affiliations
- National Cerebral and Cardiovascular Center (JP)
- Keio University (JP)
- Hyogo Medical University (JP)
- Japan Anti Tuberculosis Association (JP)
- ORCID
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2014
- Volume
- 21
- Issue
- 8
- Pages
- 784-798
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- PMC
- PMC5090819
- OpenAlex
- W2043022783
- Cited by
- 228
- References
- 58
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 25 · 2023: 25 · 2022: 34 · 2021: 33 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 10 · 2016: 12 · 2015: 4 · 2014: 2
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Atherosclerosis and Thrombosis (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cerebral and Cardiovascular Center (22-4-5)
- Japan Society for the Promotion of Science (25293147)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- coronary artery disease, Framingham risk score, risk prediction model, Japanese population, chronic kidney disease, Suita Study, risk overestimation, net reclassification improvement, 10-year risk, urban population
- MeSH terms
- Adult, Aged, Algorithms, Coronary Disease, Female, Follow-Up Studies, Humans, Japan, Male, Middle Aged, Prognosis, Risk Factors, Urban Population, Cohort Studies, Biomarkers, Incidence, Proportional Hazards Models, Case-Control Studies, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
